No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
Caution - increased level of memantine due to OCT2 inhibition. Monitor for signs of toxicity. If initiating therapy, titrate slowly. If already established on therapy, may require dose reduction. Consider choosing an alternative agent.
Caution - increased level of metformin due to OCT1/OCT2 inhibition. Monitor for signs of toxicity. If initiating therapy, titrate slowly. If already established on therapy, may require dose reduction. Consider choosing an alternative agent.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
Avoid combination - decreased level of abemaciclib due to 3A4 induction. Choose an alternative agent.
Avoid combination - decreased level of abemaciclib due to 3A4 induction. Choose an alternative agent.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
No clinically significant drug interactions identified.
Caution - increased level of both agents due to 3A4 inhibition. Monitor for signs of toxicity. Consider choosing an alternative agent.
No clinically significant drug interactions identified.